Risk factors
Evolus (EOLS) risk factors
Item 1A of every Evolus, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors59 risks10 new6 dropped10 reworded
Evolus faces risks from ongoing operating losses, including a $661.0 million accumulated deficit and $51.6 million net loss in 2025. Trade policy threats include potential tariffs on products sourced from France and South Korea. Heavy reliance on key supply partners like Daewoong and Symatese underpins commercialization of Jeuveau and Evolysse.
Filed Mar 03, 2026 - FY2024 10-K risk factors55 risks
The risk section is dominated by reliance on single-source suppliers Daewoong and Symatese for flagship products Jeuveau and Evolysse.
Filed Mar 04, 2025